Trial Site Detail
Drug: |
CS-1008 and Imatinib or Sunitinib |
|||
|---|---|---|---|---|
Trial: |
A Pilot Study of CS-1008, A Humanized Monoclonal Antibody Targeting Death Receptor 5, Alone or In Combination with Imatinib Mesylate or Sunitinib Malate In Subjects with Advanced Gastrointestinal Stromal Tumors |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Withdrawn |
|||
Fairview Health Services (University of Minnesota)2450 Riverside Ave. |
Principal Investigator: |
Keith Skubitz, MD |
|---|---|
Contact: |
Melissa Spence spenc206@umn.edu (612) 625-0673 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Fairview Health Services (University of Minnesota) Website: |
http://www.fairview.org/Research/trials/index.asp |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.